Nancy Reynolds, PhD, RN, C-NP, FAAN

• Professor
• Director - Doctoral Program

Yale School of Nursing - Rm 256A
100 Church Street South
P. O. Box 9740
New Haven, CT 06536
USA

nancy.reynolds@yale.edu

203.737.2313
203.785.6455 fax

About

Dr. Reynolds has been actively engaged in improving the quality of life of persons living with HIV since the beginning of the epidemic through her interdisciplinary leadership, research, and evidence-based practice. She is a funded investigator with the NIH, NIAID, AIDS Clinical Trials Group and recipient of NIH and AHQR funding to develop and test strategies to improve the health outcomes of HIV+ persons. In addition to her current work promoting adherence to antiretroviral medication, she is examining smoking cessation strategies in an HIV+ clinic population.

Dr. Reynolds is a regular Scientific Review Group participant of NIH, HIV special sections. She was a founding member and former president of the Association of Nurses in AIDS Care in central Ohio, an elected member of the Outcomes Committee of the National AIDS Clinical Trials Group and former Chair of the AIDS Clinical Trials Group Adherence Subcommittee, a member of the Advisory Board for the Ohio Department of Health, HIV/AIDS Drug Assistance Program (ADAP), and a contributing scientist to the World Health Organization, Adherence to Long-Term Therapies Project. Dr. Reynolds was a 2005 Fellow of the CIC Academic Leadership Program and is a Fellow of the American Academy of Nursing.

Research interests

HIV medication adherence, quality of life outcomes, self-care, symptom management, self-regulation theory

Research

Multi-site Collaborative Study for Adherence, Virologic and Clinical Outcome. PI: Liu (UCLA), NIH, NIMH, R01 MH078773

Central telephone support versus standard care for HIV+ ACTG patients reporting <95% adherence on their first antiretroviral treatment regimen. PI: Reynolds (Yale), NIH, NINR/NIAID, Adult AIDS Clinical Trials Group, AI 38858, A5251

Smoking cessation and the natural history of HIV-associated emphysema. PI: Diaz (OSU), NIH, National Heart, Lung, and Blood Institute, R01 HL090313

Adult Therapeutic Clinical Trials Program for AIDS. PI: Gulick (Cornell) NIH, NIAID, U01AI069419-01

International Trial of Clinic-based versus Home-based Directly Observed Therapy versus standard of Care for Highly Active Antiretroviral Therapy (DOT-HAART). PI: Gross (UPenn), NIH, NIAID, Adult AIDS Clinical Trials Group, AI 38858, A5234.

Yale University Home

Copyright © 2003 - 2009, Yale University School of Nursing, New Haven, Connecticut, USA.
All rights reserved. Comments or suggestions to our site editor.